Altium Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.78M Buy
23,155
+5,153
+29% +$392K 0.13% 97
2022
Q1
$1.31M Buy
18,002
+3,463
+24% +$233K 0.08% 131
2021
Q4
$907K Sell
14,539
-2,234
-13% -$131K 0.06% 163
2021
Q3
$992K Sell
16,773
-15
-0.1% -$988 0.07% 134
2021
Q2
$1.12M Sell
16,788
-2,853
-15% -$186K 0.08% 114
2021
Q1
$1.24M Sell
19,641
-1,104
-5% -$68.7K 0.1% 101
2020
Q4
$1.29M Sell
20,745
-1,914
-8% -$118K 0.11% 94
2020
Q3
$1.37M Buy
22,659
+467
+2% +$28.1K 0.14% 81
2020
Q2
$1.3M Buy
22,192
+3,888
+21% +$233K 0.15% 78
2020
Q1
$1.02M Buy
18,304
+2,015
+12% +$123K 0.14% 80
2019
Q4
$1.05M Buy
16,289
+8,285
+104% +$474K 0.13% 93
2019
Q3
$406K Buy
8,004
+292
+4% +$13.7K 0.05% 180
2019
Q2
$350K Sell
7,712
-2,027
-21% -$94.4K 0.05% 198
2019
Q1
$465K Sell
9,739
-2,756
-22% -$137K 0.07% 167
2018
Q4
$649K Sell
12,495
-10
-0.1% -$537 0.12% 118
2018
Q3
$776K Buy
12,505
+564
+5% +$33.5K 0.15% 108
2018
Q2
$661K Buy
11,941
+1,980
+20% +$107K 0.18% 97
2018
Q1
$630K Buy
9,961
+17
+0.2% +$1.09K 0.25% 67
2017
Q4
$609K Buy
+9,944
New +$622K 0.28% 65

Other funds holding BMY

Altium Wealth Management's BMY Position: Q2 2022 in Review

Altium Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 29% in Q2 2022, buying an estimated $392K and bringing the position to 23,155 shares worth $1.78M. The position accounts for 0.13% of the portfolio, ranked #97.

Altium Wealth Management first reported a position in BMY in Q4 2017 and has held it in 19 quarters since. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

  • Altium Wealth Management held 23,155 shares of Bristol-Myers Squibb worth $1.78M as of Q2 2022.
  • Altium Wealth Management bought 5,153 Bristol-Myers Squibb shares in Q2 2022, an estimated $392K.
  • Bristol-Myers Squibb made up 0.13% of Altium Wealth Management's portfolio in Q2 2022, its #97 holding.
  • Altium Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 19 quarters since.
  • 2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Altium Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.